STING enhances the formation of a complex of IRF3-Bax leading to adult T-cell leukemia/lymphoma apoptosis, suggesting that STING is responsible for anti-tumor activity against adult T-cell leukemia/lymphoma [78]. The gene discussed is STING1; the disease is lymphoma.